Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Glycosylation Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN120842292A offers shortened route for resveratrol glycosides. High purity beta-configuration suitable for osteoarthritis drug manufacturing.
Patent CN110627845A details a high-yield Rosavin synthesis. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.
Patent CN119019478B reveals novel glycosylation method for Type II Lipoteichoic Acid. Enables scalable production and cost reduction for pharmaceutical intermediates.
Novel N2-glycosyl triazole synthesis offers high yield and alpha-glucosidase inhibition for diabetes drug development and supply chain optimization.
Patent CN102241710A reveals efficient glycosylation routes for salidroside derivatives, offering cost-effective solutions for neuroprotective drug development and supply chain stability.
Novel amidation-first route for Capecitabine synthesis improves yield to 68% and purity. Cost-effective supply chain solution for oncology APIs.